Valeant Pharmaceuticals (VRX)

Add to Watchlists
Create an Alert
238.77 -2.96  -1.22% NYSE May 29, 8:00PM Delayed 2m USD
View Full Chart
VRX Price Chart
View All Events

VRX Events

Date Type Description
05/19/2015 Misc Annual General Meeting for Valeant Pharmaceuticals International Inc
04/29/2015 08:00 EDT Misc Valeant Pharmaceuticals International Inc First Quarter Earnings Conference Call in 2015
04/29/2015 Earnings Valeant Pharmaceuticals International Inc First Quarter Earnings in 2015 Release
04/01/2015 Misc Valeant Pharmaceuticals International, Inc. Completes Acquisition of Salix Pharmaceuticals
02/24/2015 08:00 EST Misc Valeant Pharmaceuticals International Inc Fourth Quarter Earnings Conference Call in 2014
02/24/2015 Earnings Valeant Pharmaceuticals International Inc Fourth Quarter Earnings in 2014 Release
01/08/2015 08:00 EST Misc Valeant Pharmaceuticals 2015 Financial Guidance Call
10/20/2014 08:00 EDT Misc Valeant Pharmaceuticals International Inc 3Q2014 Earning Conference Call
10/20/2014 Earnings Valeant Pharmaceuticals International Inc 3Q2014 Earning Result
07/31/2014 Earnings Valeant Pharmaceuticals International Inc 2Q2014 Earning Result
View All Performance Charts

VRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Valeant Pharmaceuticals is up 84.78% over the last year vs S&P 500 Total Return up 12.01%, Teva Pharmaceutical Indus up 21.49%, and Endo International up 17.31%.

PDF Report for VRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download VRX Pro Report PDF
Advertisement

VRX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Company Website: http://www.valeant.com
  • IR Website: http://ir.valeant.com/investor-relations/default.aspx
  • HQ Country: Canada
  • HQ State/Province: Quebec
  • Incorporation Country: Canada
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company that develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

VRX Excel Add-In Codes

  • Name: =YCI("VRX","name")
  • Description: =YCI("VRX","description")
  • Sector: =YCI("VRX","sector")
  • Industry: =YCI("VRX","industry")
  • Est. Current Fiscal Year End: =YCI("VRX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.